MYX 3.19% $4.85 mayne pharma group limited

Ann: Change of Director's Interest Notice, page-22

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 930 Posts.
    lightbulb Created with Sketch. 339
    MYX shares will go up in value. The current and future product line is in womens health and skin care issues. Womens health in particular wont go away in a depression/recession. MYX has a good business model. Management will improve the costs and it will succeed long term. Its not a hyped up tech company selling access to software - whose shares can dive 95%. The company has a great market and great opportunity. Its debt free with some cash to invest wisely... Opportunities may present themselves with more hormonal treatments for women from Mithra. No more generics !!! No more debt !!!! the mistakes of the teva purchase have been written out of the equation.... Business takes time to happen - just be patient.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.